皓元医药：关于“皓元转债”预计满足赎回条件的提示性公告

Core Viewpoint - Haoyuan Pharmaceutical announced that its stock price has been above 130% of the current conversion price of its convertible bonds for 10 trading days, which may trigger conditional redemption terms if the stock price remains above this threshold for an additional 5 trading days within the next 20 trading days [1] Summary by Relevant Sections - Stock Performance - The company's stock price has not fallen below 52.61 yuan per share, which is 130% of the current conversion price of the "Haoyuan Convertible Bonds" [1] - Redemption Conditions - If the stock price remains above the conversion price for 5 out of the next 20 trading days, the company has the right to redeem all or part of the unconverted "Haoyuan Convertible Bonds" at face value plus accrued interest [1]